Jim DiCesare

Aug 15, 2024 | medcitynews.com | Jim DiCesare

Barriers to participation, particularly in participant payment processes, have long challenged recruitment and retention in clinical trials. , partially due to these financial barriers. Compensation factors, including the amount, timing and method of disbursing payments, critically influence a participant’s decision to join and remain in a study — essential for equitable patient care.

May 20, 2024 | clinicalleader.com | Kerry Leyden |Caroline Potts |Jim DiCesare |Oriol Serra

Webinar: Build Your Diversity Action Plan with AI and Patient InsightsJoin us May 29th to explore how to build an effective Diversity Plan including enrollment goals, their rationale, and how to meet them. We’ll highlight how to avoid the key barriers to diversity such as implementation factors, patient access & awareness, and infrastructure changes, and you’ll learn the intricacies of prioritizing trial designs to meet FDA compliance. Click here to learn more.

Jul 18, 2023 | clinicalleader.com | Jim DiCesare

Article | July 18, 2023 By Jim DiCesare, IQVIA Clinical Trial Payments The sponsor-site relationship relies on good faith, but late payments sow mistrust. Sponsors that consolidate their payment systems in an enterprise strategy, rather than a trial-by-trial approach that varies by contract research organization (CRO) or study, improve their workflow and relationship with sites.